A recent surgical trial conducted over two year with 1,386 patients found no reduction in surgical site infection with the use of 80 percent inspiratory oxygen. However, the oxygen was associated with significantly increase long-term mortality, which was statistically significant in patients undergoing cancer surgery.
One hundred fifty-nine of 685 patients, or 23.2 percent, died in the 80 percent oxygen group, compared to 128 of 701, or 18.3 percent, assigned to 30 percent oxygen.
More Articles on Anesthesia:
Study: Brain Activity is Measured More Rapidly with Direct Measure Nitrous Oxide
Dr. Steven Sheinman Appointed to Sheridan Healthcare’s New Ambulatory Anesthesia Position
Anesthesia-Specific Billing Solution To Be Released by Fluent Medical, Nightingale Informatix
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
